 inhibitori activ cultur supernat alveolar macrophag patient interstiti lung diseas normal condit releas interleukin inhibitor role tissu homeostasi increas activ decreas inhibitori activ iha supernat alveolar macrophag healthi long-term smoker healthi nonsmok studi alter releas iha alveolar macrophag patient interstiti lung diseas sarcoidosi idiopath pulmonari fibrosi ipf activ alveolar macrophag lipopolysaccharid patient activ sarcoidosi mean SD u/ml u/ml healthi non-curr smoker hn iha alveolar macrophag differ group decreas iha patient activ sarcoidosi percent hn ipf prednisolon cultur medium physiolog concentr releas releas iha iha thymocyt prolifer human fibroblast prolifer presenc